Royalty Pharma plc (RPRX) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $19.62B | +7.7% |
| 2024 | $18.22B | +11.2% |
| 2023 | $16.38B | -2.6% |
| 2022 | $16.81B | -4.0% |
| 2021 | $17.52B | +9.3% |
| 2020 | $16.02B | +28.7% |
| 2019 | $12.45B | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $19.62B | +7.7% |
| 2024 | $18.22B | +11.2% |
| 2023 | $16.38B | -2.6% |
| 2022 | $16.81B | -4.0% |
| 2021 | $17.52B | +9.3% |
| 2020 | $16.02B | +28.7% |
| 2019 | $12.45B | — |